Regenerative Medicine

Collaboration to Accelerate Breakthroughs in Regenerative Medicine | 3D Printing Progress | 1/21/2020

Collaboration to Accelerate Breakthroughs in Regenerative Medicine 3D Printing Progress …

Gene Therapy Market Worth $13.0 Billion by 2024 - Exclusive Report by MarketsandMarkets™ | PR Newswire | 1/20/2020

CHICAGO , Jan. 20, According to the new market research report “ Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region - Global Forecast to 2024” , published by MarketsandMarkets™, is projected to reach USD 13.0 billion by 2024 from USD 3.8 billion in 2019, at a CAGR of 27.8% from 2019 to 2024. Download PDF Brochure: https …

Follow Regenerative Medicine:    

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape | PR Newswire | 1/20/2020

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape News provided by Jan 20, 2020, 14:00 ET Share this article DUBLIN , Jan. 20, 2020 /PRNewswire/ – The “Global Contract Research Organization (CRO) Market, Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering. Owing to a constantly changing pharmaceutical landscape, the industry is expected …

The Miracle of Regenerative Medicine: How to Naturally Reverse the Aging Process | 1/20/2020

Turn on the body?s self-healing abilities, prevent illness before it starts, and reverse the aging process ? Explains how to activate the body?s regenerative abilities and combat inflammation through diet, supplements, detox, herbs, exercise, energy medicine, and mindfulness ? Examines the science of epigenetics and the potential of stem cell therapies for regeneration of joints and organs as well as for healing the telomeres of our DNA ? Reveals the …

Re-Set the Hands of Time with Dr. O – Q&A Session | 1/20/2020

Meet Dr. Ifeoma (Iffie) Okoronkwo, a Regenerative Medicine and Bio-cosmetics doctor who recently launched her new practice Beyond Beauty by Dr. O in New York City. Dr. O, a Spine and Sports Rehabilitation Medicine and Pain Management physician, is board-certified in Physical Medicine and Rehabilitation at Manhattan Spine and Sports Medicine and uses her vast knowledge of all aspects of the human body to help her patients look …

Stem-cell therapy, with a growing market, comes under a microscope | Star Tribune | 1/19/2020

… umbilical cord blood or amniotic fluid left after childbirth. In an interview, Thorson acknowledged marketing mistakes by an agency that he no longer employs, but said the stem-cell injections and other forms of regenerative medicine he offers are at least safe. They also have reduced pain, increased mobility and prevented or delayed surgery for many of his patients, he said, even if medical research on those benefits is limited …

Columbia Engineering Team’s Robotic Device Aids Patients With Spinal Cord Injury | Global Indian | indiawest.com | 1/18/2020

NEW YORK – A Columbia engineering team led by an Indian American scientist has invented a robotic device that can be used to assist and train people with spinal cord injuries to sit more stably by improving their trunk control, gaining an expanded active sitting workspace without falling over or using their hands to balance. Spinal cord injuries can cause devastating damage, including loss of mobility and sensation. “We designed TruST …

JPM: Biotech, VC execs on where the industry should look beyond cancer | FierceBiotech | 1/17/2020

… Because there are so many areas of unmet need, it’s hard to say just one therapeutic area or one modality. It’s exciting: the cellular engineering that’s going to result in the ability to do regenerative medicine type efforts is I think going to be the next really amazing sort of thing. “With the fact that you can manipulate human cells now the way you can, and make multiple difficult edits …

SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results | PR Newswire | 1/17/2020

… Allergan 360° Aesthetics Report™. April 2019 . About Allergan plc Allergan plc (NYSE: AGN ), headquartered in Dublin, Ireland , is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and …

6th Perinatal Stem Cell Society Congress | Salt Lake City, United States - March 4th-6th, 2020 | PR Newswire | 1/17/2020

… Wetherell , PhD Understand How IP Drives Your Company Decision Making Process Networking Cocktail Reception & Dinner Friday, March 6, 2020 7:00 - 8:30 Breakfast in Exhibit Hall 8:30 - 9:00 Dennis Lox, MD Why A Successful Sports & Regenerative Medicine Specialist Doesn’t Use Perinatal Products 9:00 - 9:30 Duncan Ross , PhD Exosome Characterization and Visualization 9:30 - 10:00 Saadiq F. El-Amin III , MD, PhD Regenerative Medicine in Elite and Professional Athletes 10:00 - 10:30 Exhibit Hall …

Drug shows promise for treating cognitive problems and inflammation in Gulf War illness | 1/17/2020

Research Drug shows promise for treating cognitive problems and inflammation in Gulf War illness The compound, monosodium luminol, shown to improve cognitive and mood function and reduce inflammation in a Gulf War illness model January 17, 2020 Print Gulf War illness, or GWI, previously called Gulf War syndrome, is a collection of medically unexplained chronic symptoms that one-third of veterans who served in the first Gulf War experience even …

Undergraduate and Medical Students interested in regenerative medicine: Apply now for the ENGAGE Summer Training Program | 1/17/2020

Undergraduate and Medical Students interested in regenerative medicine: Apply now for the ENGAGE Summer Training Program January 17, 2020 Community Postings 0 The ENGAGE summer research training program at the National Center for Regenerative Medicine (NCRM) supports undergraduate or medical students interested in stem cell and regenerative medicine research. ENGAGE students are provided a stipend for their 8-week projects and opportunities for scientific growth by working with our renowned …

Meet the Excellent Women Scientist at StemGen 2020 | 1/17/2020

… translational research, developing gene-editing technology for possible therapeutic applications, creation of animal models for various human diseases and training programs on the various components of stem cells and regenerative medicine. Stem Cell and Regenerative Medicine (StemGen 2020), which will be held during April 20-21, 2020 carrying the theme as ‘Stem Cells: Innovations and Applications’ in Kuala Lumpur, Malaysia. StemGen 2020 warmly welcomes the researchers and developers, professionals who are …

Americollect’s Alene Meidl named to Wisconsin AAHAM Board | Manitowoc biz update | 1/17/2020

Plus, Dr. Ryan Woods will be offering regenerative medicine in Manitowoc at Orthopedics & Sports Medicine BayCare Clinic on N. 10th Street. Post to Facebook Americollect’s Alene Meidl named to Wisconsin AAHAM Board Manitowoc biz update Plus, Dr. Ryan Woods will be offering regenerative medicine in Manitowoc at Orthopedics & Sports Medicine BayCare Clinic on N. 10th Street. Check out this story on htrnews.com: https://www.htrnews.com/story/money/2020/01/17/manitowoc-business-news …

B cell count tells how certain cancers will respond to immunotherapy | 1/16/2020

Olympus Launches Innovative Incubation Monitoring System with Cell Count and Confluency Analysis to Improve the Regenerative Medicine Workflow The TLS was found to be the home of densely packed B cells. The number of TLS within the tumor was increased in responders, as was the B cell density. Not only so, the B cells themselves expressed markers that characterize mature differentiated B cells. Such markers are also found in long …

ReadCoor to commercially launch spatial sequencing platform | 1/16/2020

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine. ReadCoor, a company reinventing omics and pathology with its 3-dimensional (3D) multi-omic spatial sequencing platform, has announced a $27 million Series B financing to accelerate the commercialization of its proprietary FISSEQ technology for use in research, drug discovery, and diagnostics. “ReadCoor …

Akron Biotech CEO to Launch Children’s Book at Frost Science’s Future of Medicine Day | PR Newswire | 1/16/2020

… advanced therapy industry’s best minds together. The Phillip and Patricia Frost Museum of Science is located at 1101 Biscayne Blvd. in Miami, Florida . About Akron Biotechnology Akron Biotechnology is a leading supplier to the regenerative medicine industry. Akron develops and manufactures cGMP-compliant ancillary materials and provides specialized services in order to accelerate the clinical development and commercialization of advanced therapies. please visit us at www.akronbiotech.com . SOURCE Akron Biotechnology Related …

Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma’s Impact on Daily Living | PR Newswire | 1/16/2020

… through innovative products and outreach programs. About Allergan plc Allergan plc (NYSE: AGN ), headquartered in Dublin, Ireland , is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and …

FAU’S Online Graduate Nursing Program Soars To No. 7 In 2020 ‘U.S. News & World Report’ Rankings | PR Newswire | 1/16/2020

BOCA RATON, Fla. Florida Atlantic University ‘s Christine E. Lynn College of Nursing ‘s online master’s degree in nursing is ranked No. 7 in the nation for “ Best Online Graduate Programs “ in 2020 by U.S. News & World Report . The college soared to No. 7 from the No. 23 spot in 2019, and is the top-ranked program for private and public institutions in Florida . FAU’s College of Business , College of …

Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2020-2025 | 1/16/2020

… a market share of 89% in 2018, followed by Mouse iPSCs. Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8. - Academic Research - Toxicity Screening - Regenerative Medicine This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed …

Clinical Research

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape | PR Newswire | 1/20/2020

… regenerative medicine).As a result of a higher R&D activity, there is higher reliance on outsourcing partners (e.g., CRO vendors) that support pharma and biotech participants with cost-effective and time-efficient drug development services. The global CRO industry is a highly fragmented and competitive market, with more than 1,000 participants globally. Europe is emerging as a key location for clinical research, with several small-to-mid segment niche …

Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape | Benzinga | 1/20/2020

… regenerative medicine). As a result of a higher R&D activity, there is higher reliance on outsourcing partners (e.g., CRO vendors) that support pharma and biotech participants with cost-effective and time-efficient drug development services. The global CRO industry is a highly fragmented and competitive market, with more than 1,000 participants globally. Europe is emerging as a key location for clinical research, with several small-to-mid segment niche …

Bioprinting

Biotechnology Company Aspect Biosystems Raises $20 Million | 1/17/2020

Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, announced it raised $20 million in Series A Aspect Biosystems — a biotechnology company pioneering microfluidic 3D bioprinting of human tissues — announced recently that … and strategy in addressing multiple applications in therapeutic discovery and regenerative medicine, and will allow us to accelerate internal innovation and expand our global partnerships. With our technology platform, interdisciplinary team of scientists and engineers …

3D Bioprinting Market 2020 Upcoming Trends, Share, Top manufactures analysis, Demand, Growth Drivers, and Future Outlook to 2029 | The Wapakoneta Daily News | 1/17/2020

Reportocean.com adds has announced the new market intelligence report on “3D Bioprinting Market 2020 Upcoming Trends, Share, Top manufactures analysis, Demand, growth, and Future Outlook to 2029” The global 3D bioprinting market is expected to … Biomaterials 3D Bioprinters Application Segment is sub-segmented as: Research Regenerative Medicine Drug Testing and Development Food Testing Highlights of the Global 3D Bioprinting Market The global 3D bioprinting market research study consists of market …

Biotech

Worldwide Recombinant Cell Culture Supplements Market Insights (2019-2029): Focus on Product Type, Applications, Regional Data, Country Data, and Competitive Landscape | Financial Buzz | 1/3/2020

… Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others. Key Topics Covered Executive Summary 1 Scope of the Work 1.1 … Supplements Market (by Application) 8.1 Overview 8.2 Stem Cell and Regenerative Medicine 8.2.1 Stem Cell Therapy 8.2.2 Cell Therapy 8.2.3 Gene Therapy 8.3 Bioproduction 8.3.1 Monoclonal Antibodies 8.3.2 Recombinant Proteins 8.3.3 Vaccines 8.3.4 Hormones 8.3.5 …

Worldwide Recombinant Cell Culture Supplements Market Insights (2019-2029): Focus on Product Type, Applications, Regional Data, Country Data, and Competitive Landscape - Stocks News Feed | 1/3/2020

… Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare , Novozymes A/S, and Advanced Biotechnologies, Inc., among others. Key Topics Covered Executive Summary 1 Scope of the Work 1.1 … Supplements Market (by Application) 8.1 Overview 8.2 Stem Cell and Regenerative Medicine 8.2.1 Stem Cell Therapy 8.2.2 Cell Therapy 8.2.3 Gene Therapy 8.3 Bioproduction 8.3.1 Monoclonal Antibodies 8.3.2 Recombinant Proteins 8.3.3 Vaccines 8.3.4 Hormones 8.3.5 …

Digital Health

What will 2020 bring for medicine and science? - STAT | 12/30/2019

… Mundel, president of global health, Bill and Melinda Gates Foundation Related: 3 challenges to watch in global health in 2020 Digital health culling will begin in earnest I think 2020 will be the year that … wave we will see is the use of CRISPR in regenerative medicine to develop implantable cells in a range of organs — whether pancreas, liver or other cells. Finally, we will see additional progress with in …

Nancy E. Rolnik, MD, CAQSM, a Sports Medicine Physician with Remedy Sports and Regenerative Medicine - IssueWire | 12/26/2019

… the pain of a sports injury and missing out. When she developed tennis elbow that worsened, she finally relied on regenerative medicine to heal. She received PRP therapy that resulted in relief of daily pain … rolnik-m-d-caqsm-sportsmedicine About FindaTopDoc.com FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on …

American Academy of Orthopaedic Surgeons

The Application of Hyaluronic Acid-Based Hydrogels in Bone and Cartilage Tissue Engineering | 12/20/2019

… lymph, and the growth and proliferation of cartilage cells is slow; thus, cartilage healing is also a challenge [ 2 ] in regenerative medicine. Furthermore, problems with autografts and allografts include the source and price as well … bone and cartilage restoration in orthopaedic surgery,” Journal of the American Academy of Orthopaedic Surgeons , vol. 27, no. 5, pp. e215–e226, 2019. View at Publisher · View at Google Scholar · View at Scopus T. L …

Advancements in 3D Printing Technology Bring Promise to Orthopedic Care | 12/17/2019

Bone Screw System Market is Expected to Exceed $1.96 Billion by End of 2028 American Academy of Orthopaedic Surgeons (AAOS) 12.17.19 It is no secret that technology is transforming the healthcare industry at rapid speed … I believe we’ll start to see 3D printing focusing on regenerative medicine, joint preservation, and the ability to 3D print in biologic materials that have the potential to replace musculoskeletal tissues such as bone, cartilage …

Mental Health

Allergan Foundation Giving Reaches $95 Million Since Inception | PR Newswire | 12/19/2019

… Foundation, Depression and Bipolar Support Alliance, Alzheimer’s Los Angeles’ Dementia Health Care Initiative and Dystonia Medical Research Foundation Programs supporting Mental Health awareness including The Jed Foundation Campus Program, National Alliance on Mental Illness (NAMI … developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key …

Sunovion Announces Results from Its Open-Label Extension Study of SEP-363856 in Schizophrenia - Stocks News Feed | 12/14/2019

… Union. Sumitomo Dainippon Pharma aims to create innovative pharmaceutical products in the Psychiatry & amp ; Neurology area, the Oncology area and Regenerative medicine/Cell therapy field, which have been designated as the focus therapeutic areas. Sumitomo … detail/mental-disorders. Accessed September 2018 . 3 National Institute of Mental Health. Schizophrenia. [Internet]. Available from: https://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml . Accessed September 2018. Share this Article - Help Increase Engagement and Conversation …

Medical Education

Physicians’ Education Resource® Announces Keynote Speakers for the 37th Annual Miami Breast Cancer Conference® | Business Wire | 12/19/2019

CRANBURY, N.J.- Physicians’ Education Resource ® (PER ® ), a leading resource for continuing medical education (CME), has named Scott Gottlieb, M.D., and Nalie Agustin, as the keynote speakers for the 37 th Annual Miami Breast Cancer Conference … and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs and digital health devices. Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal , The New …

Physicians’ Education Resource® Announces Keynote Speakers for the 37th Annual Miami Breast Cancer Conference® | Business & Finance | heraldchronicle.com | Business Wire | 12/19/2019

CRANBURY, N.J.–(BUSINESS WIRE)–Dec 19, 2019– Physicians’ Education Resource ® (PER ® ), a leading resource for continuing medical education (CME), has named Scott Gottlieb, M.D., and Nalie Agustin, as the keynote speakers for the 37 th … and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs and digital health devices. Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal , The New …

Accreditation Council for Continuing Medical Education

Physicians’ Education Resource® Announces Keynote Speakers for the 37th Annual Miami Breast Cancer Conference® | Business Wire | 12/19/2019

… his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs and digital health devices. Gottlieb is widely published in leading medical … application of practice-changing advances. PER ® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER ® is a brand of MJH Life Sciences ™, the largest privately held …

Physicians’ Education Resource® Announces Keynote Speakers for the 37th Annual Miami Breast Cancer Conference® | Business & Finance | heraldchronicle.com | Business Wire | 12/19/2019

… his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs and digital health devices. Gottlieb is widely published in leading medical … application of practice-changing advances. PER ® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER ® is a brand of MJH Life Sciences ™, the largest privately held …

Medical Research

United States drops charges against two more scientists after Iran prisoner swap | Nature | 12/13/2019

… regenerative medicine. Page told Nature that if the case had come to trial, his client Jazayeri would have pleaded not guilty on the grounds that growth factors used in medical research, in his view, did not require special authorization for export to Iran. Ghaedi had bought the growth factors in the United States — where they are readily available and cheaper than in Iran — at a time when the administration of …

The Silver Health Institute Suggest That Alkaline Structured Silver Helps Prevent Colds and Flu | 12/10/2019

Regenerative Medicine and also holds a Master’s degree in Cardiac Rehabilitation and Wellness. He performed an internship with Jonas Salk, the American medical researcher noted for the discovery and development of the polio vaccine. He has formulated over 1500 products, was a Bronze medalist in the 2003 Utah Winter Games, and is a Best Selling Author. Dr. Gordon Pedersen has been published in numerous international peer reviewed scientific journals including …

Food and Drug Administration

Drug discovery and development: Health care stocks in Australia | 12/7/2019

… is into development and non-clinical studies which are required prior to submitting an Investigational New Drug Application to the Food and Drug Administration (FDA), and in 2020 it would start clinical trials. Want to … care company Regeneus Ltd (ASX:RGS) is a clinical-stage regenerative medicine company, which is into the development of new cellular therapies which target significant unmet medical needs. The key therapeutic areas of the company …

FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk - Stocks News Feed | 12/7/2019

SILVER SPRING, Md. , Dec. 6, 2019 / PRNewswire / — The U.S. Food and Drug Administration has warned Liveyon Labs Inc. (Liveyon Labs) and Liveyon LLC , of Yorba Linda, California , and their presidents and chief executive officers, Roya … highlighted in 2017 with the release of the FDA’s comprehensive regenerative medicine policy framework , including the FDA’s final guidance ( Regulatory Considerations for Human Cell, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous …

Athersys

Athersys Names Ivor Macleod Chief Financial Officer | Globe Newswire | 1/15/2020

… joins leadership team as Company begins planning for potential approval and commercialization of MultiStem® January 15, 2020 06:00 ET Source: Athersys, Inc. CLEVELAND, Jan. 15, 2020 (GLOBE NEWSWIRE) – Athersys, Inc. (NASDAQ: ATHX) announced today the … more importantly to their mission of developing best in class regenerative medicine therapies to significantly improve quality of human life,” concluded Mr. Macleod. Athersys is committed to developing therapies that address key areas of unmet …

Lifenet Health

LifeNet Health among world’s top training organizations | PR Newswire | 1/15/2020

VIRGINIA BEACH, Va. , Jan. 15, Training magazine, a leading publication for workforce development programs, has recognized LifeNet Health among its “Top 125 for 2020.” This award, given annually for the last 20 years, is among … to bio-implants and cellular therapies — and a leader in regenerative medicine, while always honoring the donors and healthcare professionals who enable healing. For more information about LifeNet Health, go to www.lifenethealth.org . SOURCE LifeNet Health …

LifeNet Health among world’s top training organiza | 1/15/2020

LifeNet Health among world’s top training organizations enero 15, 2020 LifeNet Health among world’s top training organizations 2020-01-15T10:03: VIRGINIA BEACH, Training magazine, a leading publication for workforce development programs, has recognized LifeNet Health among its … to bio-implants and cellular therapies — and a leader in regenerative medicine, while always honoring the donors and healthcare professionals who enable healing. For more information about LifeNet Health, go to www.lifenethealth.org . releases/lifenet-health …

MiMedx

The global amniotic membrane market at a CAGR of over 13% during the forecast period | Globe Newswire | 1/14/2020

… to find significant adoption in the coming years. For instance, amniotic membrane-based therapies have become an integral part of regenerative medicines. Moreover, advances in tissue preservations have resulted in the pipeline development of amniotic … Regenerative Technologies LLC, Integra LifeSciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc., Stryker Corp., Surgenex LLC, and TissueTech Inc. Also, the amniotic membrane market analysis report includes information …

Global Regenerative Medicine Market Size Study by Technology, By Source, By Application & by Region Forecast to 2027 | 1/10/2020

Bharat Book Bureau Provides the Trending Market Research Report on“ Global Regenerative Medicine Market by Technology, By Source, By Application By End-Users and By Region ”under Consumer Goods Category. The report offers a collection … Medicine Market: Competitive Landscape Companies such as Integra LifeSciences Corporation, MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic Plc., Athersys Inc., US …

RoosterBio

Stem Cell Research Markets & Products, 2019 & 2020-2024, Featuring Competitive Analysis for 128 Global Market Participants | Globe Newswire | 1/8/2020

… speciality vendors of stem cell research products, such as FUJIFILM CDI, ReproCELL and Ncardia (who specialize in iPSC-related products), RoosterBio (who specializes in human MSC-specific products), and Corning (who specializes in Matrigel products … clinical researchers is the potential to use stem cells within regenerative medicine, and the pharmaceutical industry is integrating stem cells to conduct pharmacological testing on cell-specific tissues. There is also demand for extracellular vesicles …

AveXis

Cell and Advanced Therapies Supply Chain Management Industry Report, 2019-2030 | Financial Buzz | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Atara Biotherapeutics Atomos Hyla Aurea Autodesk Autolus Therapeutics Autoscribe Informatics AveXis Avita Medical Baptist Memorial Health Care BatchMaster Software BayaTree BC Platforms Benchling Benchmark Bika Lab Systems BioCision BioFortis Biokin Pharmaceutical BioLife Solutions BioSoft Integrators …

Cell & Advanced Therapies Supply Chain Management Markets, Forecast to 2030 - In 2018, Approx $13Bn Was Invested in This Domain, Representing a 73% Increase in Capital Investments Compared to 2017 | PR Newswire | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Atara Biotherapeutics Atomos Hyla Aurea Autodesk Autolus Therapeutics Autoscribe Informatics AveXis Avita Medical Baptist Memorial Health Care BatchMaster Software BayaTree BC Platforms Benchling Benchmark Bika Lab Systems BioCision BioFortis Biokin Pharmaceutical BioLife Solutions BioSoft Integrators …

McKesson

Cell and Advanced Therapies Supply Chain Management Industry Report, 2019-2030 | Financial Buzz | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Catapult) Jill Maddux (Director, Cell and Gene Therapy Product Strategy, McKesson) and Divya Iyer (Senior Director, Corporate Strategy and Business Development, McKesson) Martin Lamb (Chief Business Officer, TrakCel) Key Topics Covered 1. PREFACE 1.1. Scope …

Cell & Advanced Therapies Supply Chain Management Markets, Forecast to 2030 - In 2018, Approx $13Bn Was Invested in This Domain, Representing a 73% Increase in Capital Investments Compared to 2017 | PR Newswire | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Catapult) Jill Maddux (Director, Cell and Gene Therapy Product Strategy, McKesson) and Divya Iyer (Senior Director, Corporate Strategy and Business Development, McKesson) Martin Lamb (Chief Business Officer, TrakCel) Key Topics Covered 1. PREFACE 1.1. Scope …

Amicus Therapeutics

John Crowley: Prescription drug pricing needs balance to serve all Americans – Here’s how to restore it | 12/16/2019

… flourish to ensure that we can translate rapidly advancing science into FDA-approved treatments. And I am confident that new regenerative medicine technologies like cell and gene therapies will increasingly help treat or even cure … the years to come. John F. Crowley is CEO of Amicus Therapeutics. Crowley’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular …

Audentes Therapeutics stock price target raised to $40 from $34 at Evercore ISI | MarketWatch | 11/19/2019

Pompe Disease Treatment Market 2019-2025, Analysis by Top Companies CENTOGENE AG., Amicus Therapeutics, Inc., Genzyme Corporation Nov. 18, 2019 at 7:22 a.m. ET on Reporthive Research Pompe Disease Treatment Market 2019 - Trends and Competitive Landscape … 2019 at 9:10 a.m. ET on Heraldkeepers The Alliance for Regenerative Medicine Announces Election of 2020 ARM Officers, Executive Committee, and Board of Directors Oct. 2, 2019 at 7:01 a.m. ET on GlobeNewswire Audentes Therapeutics …

Thermo Fisher

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Tasso Tennessee Hemophilia Terumo Thalassaemia International Federation The Medicines Company Thermo Fisher Scientific TNO Pharma Tokra Medikal Topas Therapeutics Turgut Ilaclari UCB Uniformed Services University of the Health Sciences University College Cork University of Bonn …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Tasso Tennessee Hemophilia Terumo Thalassaemia International Federation The Medicines Company Thermo Fisher Scientific TNO Pharma Tokra Medikal Topas Therapeutics Turgut Ilaclari UCB Uniformed Services University of the Health Sciences University College Cork University of Bonn …

Merck

Increased Neuronal Differentiation Efficiency in High Cell Density-Derived Induced Pluripotent Stem Cells | 12/4/2019

… gliogenesis to generate functional neurons and glia in vitro [ 14 ]. This study further indicates the valuable nature of hiPSCs for regenerative medicine. Although the supply of neurons derived from hiPSCs, including disease-specific neurons, is … extract (Life Technologies)). Medium was supplemented with 1 : 1000 mLIF (Merck Chemicals GmbH) and 1 : 500 bFGF2: EGF mixture (at 1 : 1 ratio; Sigma-Aldrich). Tissues were titrated using 1 ml tip followed by fire …

Life Sciences & Lab Equipment Market Size Projected to Increase at a CAGR of 7.37% through 2025 | 12/4/2019

… based technology ensures sufficient backup and is also a collaborative tool enabling real time monitoring and inputs by individuals. Similalry, Merck KGaA under its Accelerator Program, has come up with an innovative technology that connects … and lab equipment market. The rising trends of drug discovery, regenerative medicines, and clinical trials have led this segment to be progressing with a CAGR of 8.84%, going through up to 2025. Drug discovery and …

Pfizer

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos PhaseBio Pharmaceuticals Pieris Portola Pharmaceuticals Premier Inc Promethera Biosciences Prophylix Pharma Protagonist Therapeutics Provepharm Qiagen Quotient Bioscience Regen BioPharma Research Center …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos PhaseBio Pharmaceuticals Pieris Portola Pharmaceuticals Premier Inc Promethera Biosciences Prophylix Pharma Protagonist Therapeutics Provepharm Qiagen Quotient Bioscience Regen BioPharma Research Center …

TPG Capital

Cell and Advanced Therapies Supply Chain Management Industry Report, 2019-2030 | Financial Buzz | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Tmunity Therapeutics Total Specific Solutions Touchdown International Toyo Business Engineering TPG Capital TraceLink Triangle Research Labs Triumvirate Environmental TrueERP UMass Memorial Health Care System UNIGEN United Cargo United Parcel Service Unity Lab Services University Cancer …

Cell & Advanced Therapies Supply Chain Management Markets, Forecast to 2030 - In 2018, Approx $13Bn Was Invested in This Domain, Representing a 73% Increase in Capital Investments Compared to 2017 | PR Newswire | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Tmunity Therapeutics Total Specific Solutions Touchdown International Toyo Business Engineering TPG Capital TraceLink Triangle Research Labs Triumvirate Environmental TrueERP UMass Memorial Health Care System UNIGEN United Cargo United Parcel Service Unity Lab Services University Cancer …

GE Ventures

Cell and Advanced Therapies Supply Chain Management Industry Report, 2019-2030 | Financial Buzz | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Center French Epinal-Remiremont hospital group Gamida Cell GE Healthcare GE Ventures GEFCO Gen9 Genea Biomedx Genedata Geneva Systems Genohm GenoLogics Georgian Partners Gilead Sciences GlaxoSmithKline Goldman Sachs GPI Group Gradalis Green Cross LabCell Grenoble …

Cell & Advanced Therapies Supply Chain Management Markets, Forecast to 2030 - In 2018, Approx $13Bn Was Invested in This Domain, Representing a 73% Increase in Capital Investments Compared to 2017 | PR Newswire | 1/3/2020

… 2018), Alofisel (2018), LUXTURNA (2017), Yescarta (2017), and Kymriah (2017). Further, according to a report published by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted across the globe … Center French Epinal-Remiremont hospital group Gamida Cell GE Healthcare GE Ventures GEFCO Gen9 Genea Biomedx Genedata Geneva Systems Genohm GenoLogics Georgian Partners Gilead Sciences GlaxoSmithKline Goldman Sachs GPI Group Gradalis Green Cross LabCell Grenoble …

Longitude Capital

Talaris Therapeutics to Present at American Society of Hematology (ASH) Annual Meeting | 12/6/2019

… can be restored in patients with certain immune-mediated or blood disorders. FCR001 has received both Orphan Drug Designation and Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration. A Phase … is backed by leading life sciences investors Blackstone Life Sciences, Longitude Capital and Qiming Venture Partners USA and maintains corporate offices in Boston, MA and Louisville, KY. www.TalarisTx.com …

Talaris Therapeutics to Present at American Society of Hematology (ASH) Annual Meeting | Business & Finance | manchestertimes.com | Business Wire | 12/6/2019

… can be restored in patients with certain immune-mediated or blood disorders. FCR001 has received both Orphan Drug Designation and Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration. A Phase … is backed by leading life sciences investors Blackstone Life Sciences, Longitude Capital and Qiming Venture Partners USA and maintains corporate offices in Boston, MA and Louisville, KY. www.TalarisTx.com . View source version on businesswire.com : https://www.businesswire.com …

SVB Leerink

Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock | Globe Newswire | 11/22/2019

CANTON, Mass., Nov. 21, Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today … to customary closing conditions. Credit Suisse Securities (USA) LLC and SVB Leerink LLC are acting as joint book-running managers of the offering and BTIG, LLC and Oppenheimer & Co. Inc. are acting as co-managers …

Astellas Venture Management

Heartseed Secures $26M in Series B Funding | 11/22/2019

… since it was founded in 2015, included SBI Investment, JMDC, Gene Techno Science, Nissay Capital, SMBC Capital, and existing investor Astellas Venture Management LLC. The company will use the funds to initiate Phase 1/2 clinical … of Cardiology, Keio University, Tokyo, Heartseed develops and commercializes cardiac regenerative medicine leveraging original technologies throughout the process of manufacturing and delivering iPSC-derived cardiac regenerative medicine, including purification, cell delivery and iPSC production. FinSMEs …

Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure | BioSpace | 11/22/2019

Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure Published: Nov 22, 2019 TOKYO–( BUSINESS WIRE )– Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC … Techno Science, Nissay Capital, SMBC Capital, and an existing investor, Astellas Venture Management LLC., which has supported Heartseed from Series A. “I have been involved in the research of cardiac regenerative medicine for the past …

Apple Tree Partners

Avita Medical Names New CFO | 11/19/2019

regenerative medicine company’s Valencia office. The company’s former interim chief financial officer, Tim Rooney, will continue his role as chief administrative officer. Avita Medical makes and sells its Recell System, which helps patients regrow skin after burns or other injuries. McIntyre has more than 20 years of experience in senior financial, legal and operational roles, most recently serving as partner with Apple Tree Partners. He helped the multibillion-dollar venture …

AVITA Medical Names David McIntyre as Chief Financial Officer | 11/18/2019

… Remains with Company as Chief Administrative Officer VALENCIA, Calif. & MELBOURNE, Australia–(BUSINESS WIRE)–AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic … entities. Most recently, Mr. McIntyre served as a Partner with Apple Tree Partners (ATP), a multibillion-dollar venture capture and growth equity fund focussed exclusively on life sciences. At ATP Mr. McIntyre was responsible for …

Casdin Capital

BioLife Solutions Announces Third Quarter 2019 Financial Results | PR Newswire | 11/12/2019

… Completed the acquisition of SAVSU Technologies, Inc. (“SAVSU”). Formed cell and gene therapy bioproduction innovation co-investment accelerator program with Casdin Capital and announced initial strategic investments in iVexSol and Sexton Biotechnologies. Successfully completed 19 … HypoThermosol ® shipping and storage media are highly valued in the regenerative medicine, biobanking and drug discovery markets. These biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation …

EW Healthcare Partners

Cognate buys Cobra to boost gene therapy CDMO capabilities | 11/6/2019

Cell therapy CDMO Cognate Bioservices will add plasmid DNA and viral vector capabilities through the acquisition of Swedish manufacturer Cobra Biologics. Memphis, Tennessee-based Cognate has entered into an agreement to acquire Cobra for an undisclosed fee, led by existing Cognate investor EW Healthcare Partners. The deal adds to Cognate’s presence in the regenerative medicine space by bringing on board plasmid DNA and viral vector manufacturing capacity and expertise, complementing …

Cognate BioServices Acquires Cobra Biologics | 11/6/2019

EW Healthcare Partners and Medivate Partners participated in this round of funding for the acquisition of Cobra, and Blackrock and the sovereign wealth fund will also continue to partner with the company. The transaction creates an enhanced services provider delivering drug development and manufacturing solutions to the global cell and gene immunotherapy and regenerative medicine industries. Led by J. Kelly Ganjei, CEO, Cognate is a dynamic, results-driven, organization focused …

Maxim Group

Mesoblast limited (NASDAQ:MESO) Expected to Announce Quarterly Sales of $16.41 Million | 11/2/2019

… equity of 17.66% and a negative net margin of 536.97%. A number of analysts have issued reports on the company. Maxim Group reissued a “buy” rating and issued a $16.00 target price on shares of … biopharmaceutical company, develops and commercializes allogeneic cellular medicines. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. The company’s products under the Phase III clinical trials …

BioCardia (OTCMKTS:BCDA) Stock Price Down 5.1% | 11/2/2019

… research note on Tuesday, September 17th. They issued a “buy” rating and a $24.00 price objective on the stock. Finally, Maxim Group began coverage on shares of BioCardia in a research note on Thursday, October … quarter. About BioCardia ( OTCMKTS:BCDA ) BioCardia, Inc, a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and …

SunTrust Bank

Allergan (NYSE:AGN) Cut to “Sell” at ValuEngine - Stock Observer | 10/31/2019

… Allergan from $172.00 to $189.00 and gave the stock a “buy” rating in a research note on Thursday, September 12th. SunTrust Banks increased their target price on shares of Allergan to $185.00 and gave the … develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in …

Diamond Hill Capital Management Inc. Trims Stock Position in Allergan plc (NYSE:AGN) | 10/31/2019

… set a $184.00 price objective (up from $176.00) on shares of Allergan in a research note on Monday, September 30th. SunTrust Banks lifted their price objective on shares of Allergan to $185.00 and gave the … develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in …

Hospital for Special Surgery

State-by-state breakdown of spine, neurosurgeon moves in 2019 | 12/16/2019

… joined Johns Hopkins Neurosurgery and Suburban Hospital in Bethesda, Md. Greenbelt, Md.-based Advanced Pain Medicine Institute Orthopaedic, Sports Health & Regenerative Medicine recently added Said Oman, MD. Maine Spine surgeon Mats Agren, MD, joined Lewiston … based Orthopaedic Associates of Dutchess County. New York City-based Hospital for Special Surgery appointed Harvinder Sandhu, MD, and Andrew Sama, MD, the new co-chiefs of HSS Spine. Jorge Eller, MD, recently joined Syracuse …

100 hospitals and health systems with great orthopedic programs | 2019 | Becker’s Hospital Review | 12/4/2019

… Education Foundation, which received a $1 million grant from the state for two consecutive years to support its research into regenerative medicine. Barnes-Jewish Hospital (St. Louis). The orthopedic department at Barnes-Jewish Hospital includes … and knee replacements, well below the 2.5 percent national average. Hospital for Special Surgery (New York City). Hospital for Special Surgery has been ranked the top hospital in the nation for orthopedic surgery by U.S …

Mayo Clinic

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Mallinckrodt Pharmaceuticals Massachusetts Institute of Technology Masterlab Masters Speciality Pharma Mayo Clinic Medgenics Medial Medica MedImmune Meditrade Medline Industries Menarini Merus Labs International Metabasis Therapeutics MicroHealth Miraca Life Sciences Mitsubishi Tanabe Pharma Moberg Pharma National …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Benzinga | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Mallinckrodt Pharmaceuticals Massachusetts Institute of Technology Masterlab Masters Speciality Pharma Mayo Clinic Medgenics Medial Medica MedImmune Meditrade Medline Industries Menarini Merus Labs International Metabasis Therapeutics MicroHealth Miraca Life Sciences Mitsubishi Tanabe Pharma Moberg Pharma National …

Harvard Medical School

Anxiety, Stress, Stem Cells & Climate Change on Sharon Kleyne Talk Radio | PRWeb | 12/4/2019

Anxiety, Stress, Stem Cells & Climate Change on Sharon Kleyne Talk Radio Share Article Stem Cell Therapies for Regenerative Medicine Impact Future of Dry Eye Technologies. Nature’s Tears® EyeMist® Reduces Effects of Pollution & Relieves Dry Eye. Sharon Kleyne, Founder of Bio Logic Aqua® Research GRANTS PASS, Ore. Air Date: 2 December 2019 Guest: Ula Jurkunas, M.D., Assistant Professor of Ophthalmology at Harvard Medical School Guest: DeWayne Cecil, Ph.D., Western Region Climate …

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Greater New York Hospital Association Grifols Haemonetics Corporation HanAll Pharmaceuticals Harvard Medical School Healthcare Royalty Partners Helsinn Healthcare HemaCare Hemophilia Foundation of Southern California HEMORIO Henry Schein Heska Hologic Homology Medicines Horiba Horizon Pharma plc …

Medical University of South Carolina

Could sphingolipids help solve a racial paradox in heart disease? | 11/21/2019

IMAGE: Dr. Samar Hammad in her laboratory at the Medical University of South Carolina view more Credit: Sarah Pack, Medical University of South Carolina When it comes to cholesterol, we’ve come to accept a simple … Samar M. Hammad, Ph.D. , associate professor in the Department of Regenerative Medicine and Cell Biology at MUSC and first author of the PLOS ONE article. “So it is about time to start looking at other …

Sphingolipids associated with heart disease in African Americans with lupus | 11/21/2019

… despite the fact that they tend to have higher levels of HDL and lower levels of triglycerides. Researchers at the Medical University of South Carolina (MUSC) explored why it is that African Americans with the … Samar M. Hammad, Ph.D., associate professor in the Department of Regenerative Medicine and Cell Biology at MUSC and first author of the PLOS ONE article Hammad thinks that sphingolipid profiles could one day serve as …

MD Anderson Cancer Center

12 burning questions for Stephen Hahn, Trump’s pick to lead FDA | STAT | 11/20/2019

… Nicholas Florko @NicholasFlorko November 20, 2019 Dr. Stephen Hahn, President Trump’s nominee to lead the FDA The University of Texas MD Anderson Cancer Center S tephen Hahn, President Trump’s nominee to helm the Food and … agency even before submitting a drug application. Take the FDA’s regenerative medicine advanced therapy (RMAT) designation, which affords drug makers working on products like cell therapies some extra hand-holding from the FDA. If Hahn …

Johns Hopkins University School of Medicine

[Research Articles] Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening | 11/20/2019

… 4 Laboratory of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. 5 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 6 Pediatric Oncology Branch, National … CA 94305, USA. 12 Stanford Institute for Stem Cell and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. ↵ † Corresponding author. Email: katherinee_warren{at}dfci.harvard.edu (K.E.W.); craigt{at}mail.nih.gov (C.J.T.); mmonje{at …

Milstein Medical Asian American Partnership Foundation Announces 2019 Fellowship and Research Project Awards | PR Newswire | 10/22/2019

… geriatric medicine (under the Irma and Paul Milstein Program for Senior Health), dermatology, translational medicine, and stem cell research and regenerative medicine. MMAAP Foundation’s Fellowship Award supports one year of training for a gifted investigator … Institution: The Second Hospital of Tianjin Medical University U.S. Institution: Johns Hopkins University School of Medicine 2019 Geriatric Medicine Project Award Project Name: Association Between Retinal Microvascular Abnormalities and Incident Mild Cognitive Impairment and Dementia …

University of Texas Southwestern Medical Center

Ebony Flowers named Choi Family Postdoctoral Fellow at USC Stem Cell | 11/18/2019

Regenerative Medicine (CIRM), located at the University of California, Irvine. For nearly a year, she studied Cornelia de Lange syndrome, which causes birth defects, growth deficiencies and other serious symptoms. She then entered the PhD program at the University of Texas Southwestern Medical Center, where she studied kidney development and polycystic kidney disease in the laboratory of Professor Thomas Carroll. When it came time to pursue postdoctoral training, she wanted …

FUTURE EDITION/ 11/15/2019 | 11/13/2019

… eggs — a scientific first. The team, led by researchers at the Salk Institute for Biological Studies in California and the University of Texas Southwestern Medical Center, used specialized stem cells that can theoretically turn into … on. Some researchers have been inspired by the field of regenerative medicine, where scaffolds are used to help grow tissue that may one day be used for repairing organs or replacing grafts. They have transformed …

Cedars-Sinai Medical Center

Device Implants Need Better Labels, Advisers Tell FDA | 11/15/2019

… other neurotoxicants because of where they live. Stephen Badylak, DVM, PhD, MD, professor of surgery at the McGowan Institute for Regenerative Medicine, University of Pittsburgh, commented that if dentists could buy alternatives to amalgam at … noted Michael Weisman, MD, professor and chair in rheumatology at Cedars-Sinai Medical Center, West Hollywood, California. 2019-11-15T15:30:00-0500 …

(USA-CA-Los Angeles) Research Lab Assistant II - Per Diem | 11/13/2019

Job Information Cedars-Sinai Research Lab Assistant II - Per Diem in Los Angeles , California The Barrett Laboratory at Cedars-Sinai Medical Center Regenerative Medicine Institute is looking for a per diem Research Lab Assistant to join our dynamic group! Principal responsibilities include: Lab cleaning and maintenance duties, including washing and sterilization of glassware, operation of autoclaves and other specialized equipment. May assist in performance of experimental protocols and procedures to …

Wake Forest Baptist Medical Center

NCMS Morning Rounds 11-13-19 | 11/13/2019

… Dr. Meredith has taken on many roles including director of surgical sciences through June 2014 and surgeon-in-chief of Wake Forest Baptist Medical Center beginning in July of this year. Dr. Meredith has played … of Health (NIH) grant for Integrative Training in Trauma and Regenerative Medicine, as well as a joint project with Wake Forest School of Medicine and the National Highway Traffic Safety Administration that established a Crash …

Winston-Salem trauma surgeon Dr. J. Wayne Meredith is new President-Elect of the American College of Surgeons | 11/5/2019

Wake Forest Baptist Medical Center in July of this year. In addition to serving as the Richard T. Myers Professor and Chair, he has served 10 years as residency program director, department of surgery, Wake Forest School of Medicine. Along with serving as medical director of the Childress Institute for Pediatric Trauma, Dr. Meredith holds a cross-appointment at Wake Forest Institute for Regenerative Medicine, as well as a joint …

Hackensack University Medical Center

Emergent high fatality lung disease in systemic juvenile arthritis | BMJ | 11/12/2019

… Pediatrics , Vanderbilt University School of Medicine , Nashville , Tennessee , USA 32 Joseph M Sanzari Children’s Hospital , Hackensack , New Jersey , USA 33 Hackensack University Medical Center , Hackensack , New Jersey , USA 34 Pediatrics , Prince of Wales Hospital , New … Massachusetts , USA 69 Medicine, Institute for Stem Cell Biology and Regenerative Medicine , Stanford University , Stanford , California , USA 70 Biomedical Data Science , Stanford University , Stanford , California , USA 71 Institute for Immunity, Transplantation and Infection, Microbiology and …

Author Correction: The bone marrow microenvironment at single-cell resolution | Nature | 7/12/2019

Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY, USA Sandra Pinho Department of Pathology, Albert Einstein College of Medicine, New York, NY, USA Ilseyar Akhmetzyanova Regeneron Genetics Center, Tarrytown, NY, USA Jie Gao Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ, USA Michael C. Gutkin & Jason M. Butler Genome Technology Center, Division of Advanced Research Technologies, NYU School of Medicine, New York, NY, USA …

Healthspan

AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform | BioSpace | 10/30/2019

… of aging and to increase human longevity, announce the publication of a new paper in the peer-reviewed scientific journal Regenerative Medicine . The paper is on the engineering of allogeneic cells to be hypoimmunogenic (universal … product pipeline for use in the clinic to extend human healthspan and is seeking opportunities to form licensing and partnership agreements around its broad IP estate and proprietary technology platforms for non-core clinical applications …

Gene Therapies: The Pipeline Towards a New Era for Patients | 10/23/2019

healthspan of patients and offer new approaches to treating diseases, with a sizable pipeline in development. Early leaders in the field have focused on rare diseases which continues to open the pathway for other treatments in oncology and infectious and chronic diseases. The panel was moderated by Shyam Patel, PhD, Associate Director, Portfolio Development & Review, California Institute for Regenerative Medicine (CIRM). The panelists were: Michelle Gilson, Principal, Cannacord Genuity Inc …

Health Net

Bayer AG buys BlueRock Therapeutics for $1 bln | PE Hub | 8/8/2019

… over 12 months allowing the necessary time to secure foundational technology from the McEwen Stem Cell Institute at the University Health Network in Toronto and the Stem Cell Center at Memorial Sloan Kettering in New … leadership and operations across Canada and the U.S.” “Prioritization of regenerative medicine as a new frontier for investment allowed us to develop a position in a new field with two to three years of lead …

Versant Ventures Announces Acquisition of Cell Therapy Company BlueRock Therapeutics | Business Wire | 8/8/2019

… over 12 months allowing the necessary time to secure foundational technology from the McEwen Stem Cell Institute at the University Health Network in Toronto and the Stem Cell Center at Memorial Sloan Kettering in New … leadership and operations across Canada and the U.S.” “Prioritization of regenerative medicine as a new frontier for investment allowed us to develop a position in a new field with two to three years of lead …

Manisha Narasimhan

SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results | PR Newswire | 1/17/2020

… in Dublin, Ireland , is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands … obligation to update these forward-looking statements. CONTACTS: Allergan: Investors: Manisha Narasimhan , PhD (862) 261-7488 Media: Ember Garrett (714) 246-3525 Kaetlyn Boone (714) 330-6483 SOURCE Allergan plc Related Links http://www.Allergan.com …

SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results - GuruFocus.com | 1/17/2020

… in Dublin, Ireland , is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands … obligation to update these forward-looking statements. CONTACTS: Allergan: Investors: Manisha Narasimhan , PhD (862) 261-7488 Media: Ember Garrett (714) 246-3525 Kaetlyn Boone (714) 330-6483 View original content to download multimedia: http://www.prnewswire.com/news-releases/skinmedica …

Christine E. Lynn

New Method Detects Toxin Exposure from Harmful Algal Blooms in Human Urine | 1/17/2020

… the world.” To assess human exposure to microcystins during the 2018 algal blooms, Schaefer and faculty and collaborators from FAU’s Christine E. Lynn College of Nursing , collected urine, nasal swabs and blood from residents of … strategic plan: Healthy aging, biotech, coastal and marine issues, neuroscience, regenerative medicine, informatics, lifespan and the environment. These areas provide opportunities for faculty and students to build upon FAU’s existing strengths in research and scholarship …

FAU’S Online Graduate Nursing Program Soars To No. 7 In 2020 ‘U.S. News & World Report’ Rankings | PR Newswire | 1/16/2020

BOCA RATON, Fla. Florida Atlantic University ‘s Christine E. Lynn College of Nursing ‘s online master’s degree in nursing is ranked No. 7 in the nation for “ Best Online Graduate Programs “ in 2020 by U.S … strategic plan: Healthy aging, biotech, coastal and marine issues, neuroscience, regenerative medicine, informatics, lifespan and the environment. These areas provide opportunities for faculty and students to build upon FAU’s existing strengths in research and scholarship …

Yehiel Tal

3D Systems Partners with CollPlant to 3D BioPrint Tissues | 1/16/2020

… Hull, co-founder, and chief technology officer of 3D Systems. “We believe 3D printing to be a key technology for regenerative medicine, and this collaboration is one of many we are entering to play an … block for regenerative medicine tissues and scaffolds available today,” said Yehiel Tal, CollPlant CEO. “As the leading additive manufacturing printing solutions company, 3D Systems is the perfect partner for us. Together, we can offer the …

3D Systems and CollPlant Announce Bioprinting Collaboration | 1/15/2020

… on CollPlant’s rhCollagen. (Image courtesy of 3D Systems.) 3D printing provider 3D Systems has signed a joint development agreement with regenerative medicine company CollPlant Biotechnologies. The agreement will see the two companies collaborate to develop … block for regenerative medicine tissues and scaffolds available today,” said Yehiel Tal, CEO of CollPlant Biotechnologies. rhCollagen is shorthand for recombinant human collagen, CollPlant’s proprietary plant-derived collagen formulation. Collagen is the most common protein …

Maria Fardis

Iovance Biotherapeutics Completes Patient Dosing in Registration-Enabling Cohort 4 of the C-144-01 Melanoma Study with Lifileucel | Globe Newswire | 1/15/2020

… study of lifileucel ahead of schedule due to increased demand, bringing this potential therapy one step closer to patients,” said Maria Fardis, Ph.D., MBA, Iovance President and Chief Executive Officer. “We remain on track to … BRAF/MEK therapy if clinically indicated. Lifileucel has been granted Regenerative Medicine Advanced Therapy (RMAT), Fast Track and Orphan Drug designations in advanced melanoma. About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics aims to improve patient care …

Iovance Biotherapeutics Completes Patient Dosing in Registration-Enabling Cohort 4 of the C-144-01 Melanoma Study with Lifileucel Nasdaq:IOVA | Globe Newswire | 1/15/2020

… study of lifileucel ahead of schedule due to increased demand, bringing this potential therapy one step closer to patients,” said Maria Fardis, Ph.D., MBA, Iovance President and Chief Executive Officer. “We remain on track to … BRAF/MEK therapy if clinically indicated. Lifileucel has been granted Regenerative Medicine Advanced Therapy (RMAT), Fast Track and Orphan Drug designations in advanced melanoma. About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics aims to improve patient care …

Kenji Yasukawa

Allele and Astellas Enter into an Expanded License for the Development of iPSC Lines | The Wapakoneta Daily News | 1/13/2020

Allele Biotechnology and Pharmaceuticals, Inc. (President and CEO: Jiwu Wang, Ph.D., “Allele”), a San Diego-based private company, and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), through its Massachusetts-based subsidiary Astellas Institute for Regenerative Medicine (AIRM), entered into a licensing agreement to expand Astellas’ access to Allele’s induced pluripotent stem cell (iPSC) technologies for various cell therapy programs. Astellas, one of the largest pharmaceutical …

Ronald Reagan

H.C. Wainwright Strengthens Its M&A and Advisory Capabilities | Business Wire | 1/13/2020

… Trivium Capital Management, GoldenTree Asset Management and Arcoda Capital Management. Mr. Meyers serves on the Board of Trustees of the Ronald Reagan UCLA Medical Center, the University of Southern California’s (USC) Board of Councilors of … T.R. Winston & Company. Mr. Jakimo is a Director of the Regenerative Medicine Foundation and The Cancer Trust, both not-for-profit organizations. He also serves on corporate advisory boards at the Columbia University Center for …

Nikolai Sopko

Science Thinks It Can Regenerate Skin (Here’s Who’s Making It Happen) | 1/13/2020

… Enter one of Utah’s most groundbreaking biotech startups, PolarityTE . The company is currently striving to become the first to implement regenerative medicine into clinical practices in an attempt to replace current methods of tissue regeneration … patients have a chance at normal lives after devastating events. Nikolai Sopko MD, chief scientific officer of PolarityTE explains that the company “is a commercial-stage biotechnology company founded in 2016 by physicians and scientists …

PolarityTE Selected to Present at 2019 Cell & Gene Meeting on the Mesa | Business Wire | 9/26/2019

… 26, 2019– PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that Nikolai Sopko, MD, PhD, Chief Scientific Officer of PolarityTE, was selected to present at the … on the conference, including registration. Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference featuring more than 80 dedicated company presentations by leading public and …

Melinda Gates

Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area | Business Wire | 1/12/2020

… rights to MEDI1191 with AstraZeneca. Localized Regenerative Therapeutics: Localized production of proteins has the potential to be used as a regenerative medicine for damaged tissues. VEGF-A (AZD8601): The Phase 2a study of AZD8601 for … Defense Advanced Research Projects Agency (DARPA) and The Bill and Melinda Gates Foundation (BMGF). Additional funding is subject to agreement on scope of additional projects. View source version on businesswire.com : https://www.businesswire.com/news/home/20200112005052 …

ReadCoor, Inc. Announces $27 Million Series B Financing for Commercial Launch of 3D RNA, DNA, and Protein Spatial Sequencing Platform | Malvern Daily Record | 1/10/2020

… previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine. The platform is comprised of an instrument, kits, and data analysis and visualization … with leading research institutions, including the Chan Zuckerberg Initiative , Bill & Melinda Gates Foundation, Oregon Health State University, and Harvard University. About Fluorescent in situ Sequencing (FISSEQ) ReadCoor’s platform is powered by proprietary Fluorescent in situ …

Joseph Darling

Anika acquires two implant companies – Arthrosurface for $100M and Parcus Medical for $95M | 1/9/2020

… are consistent with Anika’s commitment to expanding our portfolio into replacement and regenerative therapies for joint preservation and restoration,” said Joseph Darling, President and Chief Executive Officer of Anika Therapeutics. “These acquisitions will significantly enhance … will solidify Anika’s position in the $7 billion sports and regenerative medicine market and strengthen our ability to deliver better patient experiences and drive sustained revenue growth that will ultimately enhance value for shareholders.” The …

Anika Therapeutics signs agreements to acquire Parcus Medical, Arthrosurface | 1/7/2020

… which are consistent with Anika’s commitment to expanding our portfolio into replacement and regenerative therapies for joint preservation and restoration,” Joseph Darling, president and CEO of Anika Therapeutics, said in the release. “These acquisitions will … will solidify Anika’s position in the $7 billion sports and regenerative medicine market and strengthen our ability to deliver better patient experiences and drive sustained revenue growth that will ultimately enhance value for shareholders.” Reference …

Jim Lang

EVERSANA and Noom announce strategic partnership to improve therapy adherence and patient engagement for complex therapies | PR Newswire | 1/9/2020

… handling side effects, navigating lifestyle changes, and finding the education and resources needed to understand their disease and care,” said Jim Lang , CEO, EVERSANA. “By integrating Noom’s proven behavioral health technology with EVERSANA’s best-in … care, plus patient engagement and satisfaction. Additionally, the promise of regenerative medicine and precision medicine demands the evolution of traditional patient services to meet the complex needs of smaller patient populations. Both EVERSANA and Noom …